Whooping cough cases in the United States have crossed the 4,500 mark in provisional 2024 counts, rising alongside a measurable decline in childhood vaccination rates. National kindergarten DTaP coverage fell below 93 percent for the 2023-24 school year, dropping from roughly 95 percent before the pandemic. The convergence of climbing pertussis tallies and shrinking immunization numbers raises a direct question: are the jurisdictions losing the most vaccine coverage also the ones generating the sharpest spikes in disease?
Pertussis cases climb as kindergarten DTaP coverage drops below 93 percent
The CDC tracks whooping cough through its weekly NNDSS tables, which publish provisional case counts by jurisdiction. Those tables record pertussis under the agency’s official 2020 case definition, the standard used for all U.S. notifiable disease reporting. The MMWR Week 24 report, covering the period ending June 15, 2024, captured jurisdiction-level figures that, when summed nationally, put the running total above 4,500 confirmed and probable cases.
That number lands against a vaccination backdrop that has weakened steadily since the start of the pandemic. A CDC MMWR analysis of the 2023-24 kindergarten school year found national coverage dropped below 93 percent for all reported vaccines, including DTaP. Before the pandemic, that figure sat at approximately 95 percent. The two-percentage-point gap may sound small, but pertussis is among the most contagious bacterial respiratory infections. Even modest drops in herd-level protection can open corridors for sustained transmission, particularly in communities where exemption clusters concentrate unvaccinated children in the same schools and child-care settings.
A separate line of evidence reinforces the trend. The CDC’s National Immunization Survey-Child, covering children born in 2021 and 2022, documented parallel declines in routine vaccination by age 24 months. That means the coverage erosion is not limited to school-entry cohorts; it reaches younger children who have not yet started kindergarten, widening the pool of susceptible contacts for infants too young to be fully vaccinated.
At the same time, pertussis has not changed its basic epidemiology. According to CDC surveillance guidance, the disease spreads through respiratory droplets and often begins with mild cold-like symptoms before progressing to severe coughing fits. Infants face the highest risks of hospitalization and death, and many acquire infection from older siblings or caregivers whose own vaccine-derived immunity has waned.
Exemption growth and pertussis incidence: a testable link
The hypothesis that states with the largest year-over-year increases in kindergarten non-medical exemptions will record the steepest rises in pertussis incidence is straightforward to test but has not yet been formally cross-tabulated in published CDC analyses. The underlying data exist in two separate public datasets. The SchoolVaxView system tracks exemption rates and coverage levels state by state and year by year, while the NNDSS weekly tables break out pertussis counts by reporting jurisdiction. Linking the two would show whether exemption hot spots overlap with case hot spots in the weeks ahead.
Several structural factors make that overlap plausible. Pertussis cycles through peaks roughly every three to five years, and the suppressed activity during the pandemic lockdown period left a larger-than-usual cohort of children and adolescents whose vaccine-induced immunity has waned without natural boosting. When those waning-immunity dynamics coincide with rising exemption rates in specific counties or school districts, local outbreaks can accelerate quickly. The disease’s high secondary attack rate among susceptible household contacts means that even a small cluster of unvaccinated children can seed wider community spread.
Local context matters as well. States differ in how easily parents can claim non-medical exemptions, how rigorously schools verify immunization records, and how quickly health departments respond when clusters appear. In jurisdictions where exemptions are simple to obtain and follow-up is limited, under-vaccinated pockets can persist for years. Those pockets may not be obvious in statewide averages, but they can drive intense transmission in individual schools or neighborhoods once pertussis is introduced.
Still, the connection between exemptions and incidence is not automatic. Pertussis reporting completeness varies by state, and some jurisdictions with high exemption rates also have strong public health surveillance that catches more cases. Others may miss milder illness altogether. Without controlling for testing practices, diagnostic methods, and reporting lags, raw case counts can overstate or understate the true burden in any single state. Differences in how clinicians use PCR testing versus culture, and whether they test only hospitalized patients or also outpatients with prolonged cough, further complicate direct comparisons.
Gaps in the data and what to watch through late summer
Several pieces of the picture are still missing. No single published NNDSS extract supplies a verified cumulative national total that pins the 4,500-case threshold to a precise week-ending date; the figure emerges from summing provisional weekly jurisdiction reports, which the CDC notes can be revised as states finalize their case investigations. That means the count could shift upward or downward in coming weeks as laboratories confirm or reclassify pending specimens. Historical experience suggests that provisional pertussis tallies often increase as delayed reports arrive, but the magnitude of that adjustment is uncertain for 2024.
Direct statements from CDC subject-matter experts on current transmission drivers are also absent from the available record. The agency’s surveillance pages and annual pertussis summaries describe the data architecture and case definitions but stop short of attributing the 2024 rise to any single cause. Without that official interpretation, outside analysts are left to infer causality from the temporal overlap between falling coverage and rising cases, while recognizing that other factors-such as changes in health care–seeking behavior, respiratory virus co-circulation, and improved diagnostic access-may also play roles.
Another limitation is geographic resolution. State-level vaccination coverage and exemption figures can mask sharp within-state disparities. Urban districts with strong school-entry enforcement may maintain high DTaP uptake even as neighboring rural or suburban areas see larger exemption growth. NNDSS jurisdiction codes likewise aggregate cases at the state or city level, obscuring the school-level clusters that often drive outbreaks. Without more granular public data, any attempt to align exemptions with incidence must be interpreted cautiously.
Through late summer and into the fall school term, several indicators will be worth watching. Weekly pertussis counts will show whether the early-year rise is plateauing or accelerating as travel and camps bring children into new mixing patterns. Updated kindergarten coverage estimates for the 2024-25 school year will reveal whether the post-pandemic slide in vaccination is stabilizing or continuing. If both trends move in the wrong direction-more exemptions and more cases-public health agencies may face renewed pressure to tighten exemption policies and expand outreach to hesitant families.
For parents and pediatricians, the practical takeaway is concrete. The DTaP series requires five doses, with the final shot recommended between ages four and six, right before kindergarten entry. Ensuring children are up to date before school starts reduces their personal risk and helps shield vulnerable classmates, including infants and those with medical conditions that prevent full vaccination. For adolescents and adults, staying current on Tdap boosters helps close the transmission loop that so often brings pertussis into the home. While the full story of the 2024 surge is still unfolding in the surveillance data, the tools to blunt its impact-routine vaccination, timely diagnosis, and rapid response to school-based clusters-are already in hand.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
